《J Autoimmunity,2月26日,The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-02-27
  • The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

    Author links open overlay panelHussin A.RothanaSiddappa N.Byrareddybcd

    Show more

    https://doi.org/10.1016/j.jaut.2020.102433

    Abstract

    Coronavirus disease (COVID-19) is caused by SARS-COV2 and represents the causative agent of a potentially fatal disease that is of great global public health concern. Based on the large number of infected people that were exposed to the wet animal market in Wuhan City, China, it is suggested that this is likely the zoonotic origin of COVID-19. Person-to-person transmission of COVID-19 infection led to the isolation of patients that were subsequently administered a variety of treatments. Extensive measures to reduce person-to-person transmission of COVID-19 have been implemented to control the current outbreak. Special attention and efforts to protect or reduce transmission should be applied in susceptible populations including children, health care providers, and elderly people. In this review, we highlights the symptoms, epidemiology, transmission, pathogenesis, phylogenetic analysis and future directions to control the spread of this fatal disease.

  • 原文来源:https://www.sciencedirect.com/science/article/pii/S0896841120300469
相关报告
  • 《SSRN,2月19日,The Risk of Death in 2019 Novel Coronavirus Disease (COVID-19) in Hubei Province》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-20
    • The Risk of Death in 2019 Novel Coronavirus Disease (COVID-19) in Hubei Province 40 Pages Posted: 19 Feb 2020 Vincent Yi Fong Su Taipei Veterans General Hospital - Department of Chest Medicine Yao-Hsu Yang Chang Gung Memorial Hospital - Health Information and Epidemiology Laboratory Abstract Background: The current outbreak of novel coronavirus (2019-nCoV or SARS-CoV-2) in China and globally requires urgent research to guide the appropriate treatment of patients with coronavirus disease 2019 (COVID-19). Methods: We conducted a case-control study to the evaluate risk factors of death in patients with COVID-19. We used published data of cases from Huanan Seafood Market, Jinyintan Hospital, and deaths publicly released by the Government. The study included 41 patients partially exposed to the Huanan Seafood Market, 99 patients from Jinyintan Hospital, and 32 deaths (COVID-19 death group).
  • 《JAMA,4月10日,Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-04-11
    • Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China An Pan, PhD1; Li Liu, MD, PhD1; Chaolong Wang, PhD1; et al Huan Guo, MD, PhD2; Xingjie Hao, PhD1; Qi Wang, MD, PhD1; Jiao Huang, PhD1; Na He, PhD3; Hongjie Yu, PhD3; Xihong Lin, PhD4,5; Sheng Wei, MD, PhD1; Tangchun Wu, MD, PhD2 Author Affiliations Article Information JAMA. Published online April 10, 2020. doi:10.1001/jama.2020.6130 Abstract Importance Coronavirus disease 2019 (COVID-19) has become a pandemic, and it is unknown whether a combination of public health interventions can improve control of the outbreak. Objective To evaluate the association of public health interventions with the epidemiological features of the COVID-19 outbreak in Wuhan by 5 periods according to key events and interventions.